Hematologic Cancers

Advances in Management of Chronic Lymphocytic Leukemia (CLL)

Adam Kittai, MD, MBA
Pacritinib for the Management of Myelofibrosis

Prithviraj Bose, MD
Current Approach to Management of CML

Elias Jabbour, MD
Management of Ph+ALL – A Success Story

Elias Jabbour, MD
Role of BCL-2 Inhibitors in the Management of AML

Catherine Lai, MD, MPH
CLL: State of the Art

Elias Jabbour, MD
Treatment of Ph+ ALL in the Modern Era: TKI Selection, Chemotherapy-free Regimens, and the Evolving Role of Transplant

Nicholas Short, MD